Welcome to the SPEX & Medcity Investment Portal
WHO WE ARE
Spex Capital is a digital health and med-tech investment management firm specialized in advancing disruptive early-stage ventures to deliver breakthroughs in healthcare systems globally.
MedCity is the cluster organisation for the world-leading health and life sciences sector in London and the Greater South East of England. We were set up in 2014 by the Mayor of London and the region’s Academic Health Science Centres to drive growth and investment in the sector for the health and wealth of the population.
OUR INVESTMENT CALL
SPEX and MedCity have partnered to identify and fund early-stage health tech ventures and accelerate their route to commercialisation. This exclusive partnership will support several calls for innovative companies seeking investment over the next two years.
The call is targeted at innovative health tech companies, from Seed to Series A, with a solution to a problem faced by healthcare systems globally. We offer access to investment and advisory teams with deep sector experience and aim to close investments of between £500k - £5 million in a number of the most promising companies.
Please see below for FAQs and instructions for the application
The first call is now open and we will be accepting applications until midnight of 12th November 2021.
Applicants who have completed the application will undergo two levels of screening, from both SPEX and MedCity.
We expect to contact applicants about their progress and arrange in-person interviews with the successful applicants at the beginning of 2022.
We will aim to finalise investments in some of the successful applicants at the beginning of 2022.
In cases where the companies timeline requires a quicker deployment of funding we will endeavour to accelerate our due diligence progress.